ScholarIQanswers from OpenAlex

Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study

PaperCitations, authors & open-access status

Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study have?

ScholarIQcitation count

Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study has 126 citations in the OpenAlex counts ScholarIQ stores.

When was Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study published?

ScholarIQyear

Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study has 2016 year in the ScholarIQ index.

What is the open-access status of Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study?

ScholarIQoa status

Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study has closed oa status in the ScholarIQ index.

What is the DOI of Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study?

ScholarIQdoi

The DOI for Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study is on the source record.

What is the PMID of Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study?

ScholarIQpmid

The PMID for Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study is on the source record.

What is the OpenAlex record for Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study?

ScholarIQopenalex

The OpenAlex for Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial